Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
A systematic review of matched cohort and case-control studies was performed to examine the mortality attributable to candidemia. The review included studies that compared mortality of patients with candidemia (cases) to that of matched patients without candidemia (controls). Secondary variables examined were the length and cost of hospital stay. Relevant studies were identified using the PubMed database and by examining the references of the initially selected studies. Two independent reviewers performed the literature search, study selection and data extraction from the identified studies. A total of seven studies were included in the review. The patients included those hospitalized in intensive care units (ICU) and hospital wards and those undergoing transplantation. The mortality attributed to candidemia in the reviewed studies ranged from 5 to 71%. For six of the reviewed studies the difference in mortality between cases and controls was statistically significant. Among those who survived, the length of stay and the cost of hospitalization of patients with candidemia were significantly higher than those of controls. Despite the methodological heterogeneity of the reviewed studies, the data from the available matched cohort and case-control studies suggest that candidemia is associated with considerable mortality that is attributed, at least to some degree, to the infection itself and not only to the presence of another comorbidity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Estimates of mortality attributable to candidemia range from 5% to 71%, varying based on setting, age group, and study design [10].”
From Burden of Candidemia in the United States, 2017 (2020) · cites this paper as [10]
In the citing paper
“The mortality attributed to candidemia, in the reviewed studies, ranged from 5 to 71%, and for six, the difference in mortality between cases and controls was statistically significant.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [14]
Citations
Cites
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 1×
“It should be noted, as also stated by the authors of the study, that this definition is not in accordance with the Infectious Diseases Society of America (IDSA) guidelines for treatment of candidiasis [19]; these consider treatment for candidemia adequate if amphotericin B, fluconazole or caspofungin continues for 2 w…”
ResultNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · cited 1×
“This is also stressed in other articles [17, 18].”
ResultSecular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140 · cited 8×
“It is also interesting that when the results were analyzed using matched-pair analysis, the difference between cases and controls in the median number of days spent in hospital was further augmented [12, 13].”
BackgroundResultInfluential(1999) · American Journal of Infection Control · doi:10.1016/s0196-6553(99)70031-3 · Cited by 901
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831 · cited 8×
“[13] performed matching according to disease severity.”
BackgroundResultInfluentialZaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005) · Clinical Infectious Diseases · doi:10.1086/496922 · Cited by 784 · cited 7×
“length of hospital stay of adult cases was more than double that of controls [10].”
BackgroundMethodResultInfluential
Cited by
Items 201–293 of 293
Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures
Petrosillo, N., & Cataldo, A. (2011) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s11895 · Cited by 9
Maraki, S., Lionakis, S., Ntaoukakis, M., Barbounakis, E., Ntasis, E., Kofteridis, D. P., & Samonis, G. (2010) · Medical Mycology · doi:10.3109/13693786.2010.538443 · Cited by 7
Zand, F., Mohsen, Davarpanah, M. A., Masjedi, M., Nikandish, R., Amanati, A., Afarid, M., Nafarieh, L., & Nami, M. (2016) · Bioscience Biotechnology Research Communications · doi:10.21786/bbrc/9.3/6 · Cited by 7
Candidemia in critically ill patient: An analysis of daily antifungal therapy related costs
Vandijck, D. M., Blot, S. I., Labeau, S. O., Buyle, F. M., Depaemelaere, M., Vandewoude, K., & Decruyenaere, J. M. A. (2008) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2008.04.006 · Cited by 9
Leveduras nos tratos urinário e respiratório: infecção fúngica ou não?
Vidigal, P. G., & Svidzinski, T. I. E. (2009) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442009000100009 · Cited by 19
“Falagas et al.(28) também concluíram a existência de um considerável grau de associação entre candidemia e mortalidade atribuída.”
Kalkancı, A., Saraçlı, M. A., Guzel, O., Yıldıran, Ş. T., Şenol, E., & Kuştımur, S. (2007) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2007.09.003 · Cited by 7
González, M. C., & González, J. C. M. (2008) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(08)70026-3 · Cited by 13
“La candidemia condiciona un incremento en la estancia en UCI, en la estancia hospitalaria y en los costes [11,33].”
BackgroundA Case of Candidemia after Long-term Presence of Urethral Foreign Bodies
Nagata, J., Kawasaki, T., Iesato, K., Sugiura, T., Yamauchi, K., Tsuyusaki, J., Fujimura, M., Kuroda, F., Mikami, K., Dudek, S. M., et al. (2021) · IDCases · doi:10.1016/j.idcr.2021.e01176 · Cited by 7
Elhoufi, A. M., Ahmadi, A., Asnaashari, A. M. H., Davarpanah, M. A., Bidgoli, B. F., Moghaddam, O. M., Torabi-Nami, M., Abbasi, S., El-Sobky, M., Ghaziani, A., et al. (2014) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v3.i4.102 · Cited by 7
“As such, C. glabrata and Candida parapsilosis ( C. parapsilosis ) are now ranked as second in the Northern Europe and the United States [26,27] , and in Latin America and Southern Europe [28,29] , respectively.”
Advances in the management of fungal infections
Muñóz, P., Valerio, M., Vena, A., Bouza, E., Posteraro, B., Lass‐Flörl, C., & Sanguinetti, M. (2015) · Mycoses · doi:10.1111/myc.12332 · Cited by 6
Employing machine learning for identifying antifungal compounds against Candida albicans
de Souza, D. R., Silva, L. D. C., Silva, K. S. F. E., de Jesus, F. S., de Oliveira, A. A., Neves, B. J., & Pereira, M. (2025) · Future Microbiology · doi:10.1080/17460913.2025.2525717 · Cited by 6
Dowdy, H., Kumar, R. S., Almansour, A. I., Arumugam, N., Alaqeel, S. I., & Thangamani, S. (2022) · Pathogens and Disease · doi:10.1093/femspd/ftac013 · Cited by 5
Hernández-Chávez, M. J., Martínez-Duncker, I., Clavijo-Giraldo, D. M., López-Ramírez, L. A., & Mora-Montes, H. M. (2024) · Journal of Fungi · doi:10.3390/jof10070502 · Cited by 5
“Nosocomial bloodstream Candida infections are found worldwide and are a life-threatening disease with high mortality rates of up to 71% [2,3].”
BackgroundSteuber, T. D., Tucker-Heard, G., Edwards, J. D., Sawyer, A., Thottacherry, E. D., & Hassoun, A. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115086 · Cited by 5
Amorim-Vaz, S., Coste, A. T., Tran, V. D. T., Pagni, M., & Sanglard, D. (2021) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2021.658899 · Cited by 6
“50%, highlighting the inefficacy of available antifungal treatments (Falagas et al., 2006; Leroy et al., 2009; Pfaller and Diekema, 2010).”
BackgroundLongitudinal Evaluation of Plasma Cytokine Levels in Patients with Invasive Candidiasis
Wunsch, S., Zurl, C., Strohmaier, H. M., Meinitzer, A., Rabensteiner, J., Posch, W., Lass‐Flörl, C., Cornely, O. A., Pregartner, G., König, E., et al. (2021) · Journal of Fungi · doi:10.3390/jof7020101 · Cited by 8
“Since invasive Candida infections primarily occur in patients with serious underlying diseases, it is often difficult to differentiate between attributable mortality of candidemia and mortality owing to comorbidities [5].”
BackgroundIssues in the design and interpretation of antifungal drug trials in the critically ill
Ostrosky-Zeichner, L. L. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328331fc5f · Cited by 6
Khater, E. S. (2014) · British Microbiology Research Journal · doi:10.9734/bmrj/2014/7879 · Cited by 7
Hasan, M. J., Neelotpol, S., & Rabbani, R. (2022) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2022-0006 · Cited by 4
Diagnosis and treatment of sepsis-induced cardiomyopathy using hemosorption therapy: a case report
Викторович, Д. С., Kirilin, V. V., Ivanov, N. M., & Ryabov, V. V. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5355 · Cited by 4
Jaruvongvanich, V., Worasilchai, N., Kongnatthasate, K., Jaruvongvanich, S., Damkerngsuntorn, W., Atikarnbodee, D., Thammahong, A., Lerdlitruangsin, S., & Chindamporn, A. (2016) · Asian Biomedicine · doi:10.5372/1905-7415.1001.468 · Cited by 6
“Candidemia in hospitalized patients is associated with a higher attributable mortality, ranging from 5%−71%, a significantly increased cost of healthcare, and an increased length of hospital stay [3, 4].”
Lahfa-Hassaine, I., Boucherit‐Otmani, Z., Sari-Belkharroubi, L., & Boucherit, K. (2017) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.01.012 · Cited by 9
Abe, M., Kinjo, Y., Koshikawa, T., & Miyazaki, Y. (2024) · Medical Mycology Journal · doi:10.3314/mmj.24.006 · Cited by 4
Villanueva-Cotrina, F., Béjar, V., Guevara, J., Cajamarca, I., Medina, C., Mujica, L., & Lescano, A. G. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10044-5 · Cited by 4
Alexandru Vasile, R. U. S. U., Penedo, B. Á., Schwarze, A.-K., & Trif, M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92791 · Cited by 10
SUSCEPTIBILITY OF CANDIDA SPECIES TO ANTIFUNGAL DRUGS IN WESTERN INDIA
Vaghela, G., Purohit, L. N., & Kariya, P. V. (2015) · National Journal of Medical Research · Cited by 5
Maldonado, I., Canigia, L. F., Vivot, W., Domecq, P., Davel, G., & Córdoba, S. B. (2011) · PubMed · doi:10.1590/s0325-75412011000200010 · Cited by 6
Laderas, J. C. P. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70012-9 · Cited by 2
Detection of Candida albicans from Positive Blood Culture Bottles
Saad, U., Siddiqui, S., Jamil, N., Jamil, S., & Hafiz, S. (2013) · International Journal of Pathology · Cited by 3
Candidémie et candidose généralisée
Eggimann, P., & Pittet, D. (2010) · EMC-Anesthésie réanimation/Encyclopédie médico-chirurgicale. Anesthésie, réanimation · doi:10.1016/s0246-0289(10)50741-2 · Cited by 4
Oral Candidiasis Susceptibility of Mice Lacking Interferon Regulatory Factor 3, A Preliminary Report
Alsalleeh, F. M. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.14.002571 · Cited by 2
“For example, individuals with diabetes mellitus, HIV infection, chronic systemic immune-suppressor drugs usage, or patients in intensive care units or having cancer are at high risk to develop persistent candida infection or recurrent episodes [1,2].”
BackgroundCandidemia y candidiasis generalizada
Eggimann, P., & Pittet, D. (2010) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(10)70439-4 · Cited by 2
Bilal, H. M. (2017) · Archives of Cancer Science and Therapy · doi:10.29328/journal.acst.1001003 · Cited by 3
“It is evident from the previously published studies that candidemia accounts for 10-50% of the mortalities among hospitalized cancer patients [2, 3].”
BackgroundThe Impact of Antifungal Drug Resistance in the Clinic
Lewis, R. E., & Kontoyiannis, D. P. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch23 · Cited by 2
González, J. C. M., González, M. C., & Gil, C. L. (2008) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(08)70028-7 · Cited by 3
Early-onset candidemia: An increasing problem?*
Corona, A., & Singer, M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181abf8e6 · Cited by 2
Alvandian, A., Jawadi, M. H., Altıntaş, Z. N., Yıldız, N., & Karaman, M. (2016) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2016.069 · Cited by 1
Yılmaz, K., Demiray, T., Köroğlu, M., Hatipoğlu, H., Kılıç, Ü., Karabay, O., & Altındiş, M. (2020) · Mediterranean Journal of Infection Microbes and Antimicrobials · doi:10.4274/mjima.galenos.2019.2019.37 · Cited by 1
Pipaliya, B. P., Norris, S. C., Patel, D. V., Mavani, M. L., & Javadekar, T. B. (2024) · IP International Journal of Medical Microbiology and Tropical Diseases · doi:10.18231/j.ijmmtd.2024.044 · Cited by 1
“15 The high isolation rate of C. tropicalis and C. parapsilosis highlights the shifting landscape of candiduria, with these species increasingly recognized as important Uropathogens.”
BackgroundAzzawi, M. A. D. A., Abdat, W., Alhamed, A., Alhothali, A. S. A., Alsheikh, R., Almajed, H. M., Alhamdi, S. I. S., Alshahrani, N. N. A., & Eltayeb, A. O. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.116994 · Cited by 3
Canbay, A. E., & Glöckner, A. (2013) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-013-0262-y · Cited by 1
Problems related to antifungal prescription: a qualitative study of the views of intensivists
Salci, T. P., Batilana, A. P., Pietrobon, R. S., & Caparroz‐Assef, S. M. (2014) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12181 · Cited by 1
“6% in patient survival [23,24].”
Early Recognition of Invasive Candidiasis in the ICU
Charles, P., Bruyère, R., & Dalle, F. (2012) · Springer eBooks · doi:10.1007/978-3-642-25716-2_29 · Cited by 2
“Invasive candidiasis, mainly due to Candida albicans, is a life-threatening complication encountered in intensive care units (ICUs) [1, 2].”
BackgroundSelection for Candida Non-albicans spp. After Fluconazole Use
Dimopoulos, G., & Falagas, M. E. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181898761 · Cited by 1
Self-citationPinpointing Prognostic Indicators of Fungal Infections in Transplant Patients
Baddley, J. W. (2009) · Future Microbiology · doi:10.2217/17460913.4.1.77 · Cited by 2
Jiman-Fatani, A. A., Meawed, T. E., & El-Hossary, D. (2015) · The International Arabic Journal of Antimicrobial Agents · doi:10.3823/770 · Cited by 1
Fungal infections in Intensive Care Service of a specialized hospital Adults
Gill, G. (2016) · Revista del Nacional (Itaguá) · doi:10.18004/rdn2015.0007.02.007-014 · Cited by 2
Probiotics in Invasive Candidiasis
Colombo, J., & Arena, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00048-4 · Cited by 2
Ferrer, R., Zaragoza, R., Llinares, P., Maseda, E., Rodríguez, A. H., & Quindós, G. (2016) · Medicina Intensiva (English Edition) · doi:10.1016/j.medin.2016.07.003 · Cited by 2
EPICO 3.0. Management of non-neutropenic patients in medical wards
Ferrer, R., Zaragoza, R., Rodríguez, A. H., Maseda, E., Llinares, P., Grau, S., Álvarez-Lerma, F., Quindós, G., Salavert, M., & Huarte, R. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.06.003 · Cited by 1
Growth and Control of Catheter-related Bloodstream Infection Causing Bacteria in Nutrient Solutions
Ohara, H. (2022) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.21-00184 · Cited by 1
Hwang, Y.-Y., Kang, O., Park, C.-E., Hong, S.-N., Kim, Y.-K., Huh, H. J., & Lee, N. Y. (2022) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2022.54.2.110 · Cited by 2
Sawyer, R., Chou, J., McLaren, G., & Cheng, A. W. (2022) · World Journal of Surgical Infection · doi:10.4103/wjsi.wjsi_13_22 · Cited by 1
Using Bioluminescence to Image Candida glabrata Urinary Tract Infections in Mice
Schrevens, S., Torelli, R., Sanguinetti, M., & Sanglard, D. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3155-3_17 · Cited by 1
Growth of Candida albicans in Peripheral Parenteral Nutrition Solutions Supplemented with Biotin
Ohara, H., Matsuzaki, T., & Hayasaka, M. (2017) · Japanese Journal of Infection Prevention and Control · doi:10.4058/jsei.32.29 · Cited by 2
Belotserkovskiy, B. Z., Гельфанд, Е. Б., Bykov, A. O., Mamontova, O. A., & Николаевич, П. Д. (2019) · Surgery and Oncology · doi:10.17650/2686-9594-2019-9-4-11-20 · Cited by 1
Detecting Invasive Fungal Disease in Surgical Patients: Utility of the (13)- β- d -Glucan Assay
Skubic, J. J., Taghavi, S., Castillo‐Angeles, M., Ramsis, R., Salim, A., & Askari, R. (2020) · Surgical Infections · doi:10.1089/sur.2019.247 · Cited by 2
“invasive fungal infections continue to carry a high mortality rate [2,3].”
An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Monasky, R. C., Villa, S., & Thangamani, S. (2020) · Journal of Visualized Experiments · doi:10.3791/61488 · Cited by 1
Anidulafungin: a new addition to the antifungal armamentarium
Mohr, J., & Ostrosky-Zeichner, L. L. (2007) · Therapy · doi:10.2217/14750708.4.2.125 · Cited by 3
“Despite large advances in the development of antifungal drugs, invasive fungal infections continue to contribute greatly to the overall morbidity and mortality in immunocompromised patients [1].”
BackgroundMagri, M. M. C. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-07022013-115954
Candida Albicans: New Insights in Infection, Disease, and Treatment
MacCallum, D. M. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6397-8_5 · Cited by 2
Lo, J., Lo, J. O.-T., & Hunter, A. J. (2008) · Journal of Hospital Medicine · doi:10.1002/jhm.305
Candida-Infektionen – Diagnose und Therapie
Kratzer, C., & Tobudic, S. (2010) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-010-0067-3
Candidemia e candidosi generalizzata
Eggimann, P., & Pittet, D. (2010) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(10)70266-8 · Cited by 1
Prophylaxis for Candida in the intensive care unit patient
Ostrosky-Zeichner, L. L. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0011-5
Loh, L. C., Yii, C. T.-J., & Tong, J. M. G. (2012) · Journal of Medical Microbiology & Diagnosis · doi:10.4172/2161-0703.1000105
“baumannii cases, makes any conclusion difficult [11].”
An evaluation of intravenous antifungal medications in patients in a paediatric hospital
Rajan, R. T. (2008) · eSpace (Curtin University)
Macêdo, D. S., Magalhães, H. I. F., do Nascimento, F. B. S. A., Serpa, S., Júnior, H. V. N., Cavalcanti, B. C., da Câmara, C. A. G., Silveira, E. R., Neto, J. B. D. A., Lima, I. S. P., et al. (2015)
ITY OF BLOODSTREAM INFECTIONS IN PATIENTS WITH SEVERE BURN INJURY
Vogelaers, D. (2010)
Estudo retrospectivo de dez anos de candidemia em hospital terciário de Campo Grande-MS, Brasil
Bonfietti, L. X., & Melhem, M. D. S. C. (2011) · BEPA Boletim Epidemiológico Paulista
Canbay, A. E., & Glöckner, A. (2013) · Wiener klinisches Magazin · doi:10.1007/s00740-015-0060-7
“Zahlenmäßig bleiben invasive Pilzinfektionen deutlich hinter den bakteriell verursachten zurück, jedoch ist die Inzidenz offenbar im Anstieg begriffen und die Letalität insbesondere bei inadäquater oder zu spät begonnener Initialtherapie ausgesprochen hoch [15, 17, 28].”
BackgroundiNKT Cells Participate in the Exacerbation of Systemic Candidal Infection
Tarumoto, N., Kinjo, Y., Kitano, N., Shibuya, K., Maesaki, S., & Miyazaki, Y. (2014) · Medical Mycology Journal · doi:10.3314/mmj.55.j115
Fungal Diagnostics: A Practical Approach
Kaewpoowat, Q., Nachimuthu, N., & Ostrosky-Zeichner, L. L. (2016) · Current Clinical Microbiology Reports · doi:10.1007/s40588-016-0036-4
Pinhati, H. M. S. (2015) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2015.10.t.19942 · Cited by 3
Épidémiologie des infections invasives à candida au Centre Hospitalier Universitaire d'Amiens
Garnier, J. (2015) · HAL
Epidémiologie des candidoses invasives en réanimation : dernières données
Gauzit, D. L. C. D. R. (2008) · Réanimation · doi:10.1016/s1624-0693(08)74003-9
The Effect Of Candida Infections On Mortality Of ICU Patients: Results Of Sixty-Three Patients
(2008) · The Internet Journal of Emergency and Intensive Care Medicine · doi:10.5580/176e
“Besides, in several publications it is notified that in Candida infections increases mortality rate (5, 6, 9, 16, 17, 18, 19).”
BackgroundYeast Infections After Haematopoietic Stem Cell Transplantation
Trubiano, J. A., Chen, S. C.-A., & Slavin, M. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_37
Boutoille, D., Tattevin, P., Weinbreck, P., Ansart, S., Hutin, P., Leautez-Nainville, S., Raffi, F., Hôtel-Dieu, C., & de Limoges, C. (2009)
Al-Sofyani, K. A., Uddin, M. S., Alghamdi, H. S., & El-Hossary, D. (2020) · Acta Scientific Paediatrics · doi:10.31080/aspe.2020.03.0318 · Cited by 1
Alanio, A., & Chen, S. C.-A. (2020) · Hematologic malignancies · doi:10.1007/978-3-030-57317-1_15
Reyes, S., Hernández-Gómez, C., Pallares, C., Salcedo, S., Valderrama, S., Ordóñez, K., Correa, A., & Villegas, M. V. (2019) · Research Square · doi:10.21203/rs.2.10675/v1
Zheng, Y., Xie, T., Wu, L., Liu, X., Zhu, L., Chen, Y., Mao, E., Han, L., Chen, E., & Yang, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-212048/v2
Zheng, Y., Xie, T., Lin, W. U., Xiao-Ying, L. I. U., Zhu, L., Chen, Y., Mao, E., Han, L., Chen, E., & Yang, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-212048/v1
Synergistic Inhibition of Candida albicans Growth by Plant Extract CombinationsPreprint
Jeemin, Y. O. O. N., & Kim, T. (2022) · Research Square · doi:10.21203/rs.3.rs-2249470/v1
Media Optimization and Partial Purification of Anti-Candida Compound of Probiotics Cultures
Anand, P. K., Aswani, M. A., Kathade, S. A., & Kunchiraman, B. N. (2022) · Current Applied Science and Technology · doi:10.55003/cast.2022.04.23.010 · Cited by 1
Singh, R., Kakati, B., & Mittal, G. (2025) · Cureus · doi:10.7759/cureus.86241
“The increasing prevalence of NAC species, many of which demonstrate resistance to fluconazole and other antifungal agents, complicates treatment and underscores the urgent need for enhanced surveillance, early diagnosis, and the implementation of antifungal stewardship programs [7,8].”
15 Antifungal Pharmacokinetics
Farowski, F., & Cornely, O. A. (2013) · Springer eBooks · doi:10.1007/978-3-642-39432-4_15 · Cited by 1
Moragues-Solanas, L., Le-Viet, T., McSorley, E., Halford, C. M., Lockhart, D. S., Aydin, A., Kay, G. L., Elumogo, N., Mullen, W. H., O’Grady, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25347035
Moragues-Solanas, L., Le-Viet, T., McSorley, E., Halford, C. M., Lockhart, D. S., Aydin, A., Kay, G. L., Elumogo, N., Mullen, W. H., O’Grady, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25347255
Characteristics of fungaemia caused by Trichosporon species in South-Eastern Europe
Varlamis, S., Pessach, I., Kyriazidi, M. A., Gavriilaki, E., Mavridou, M., Mitka, S., Chatzidimitriou, M., & Vyzantiadis, T. (2026) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.2026.02852
Tiwari, P., Rai, A. K., Varnika, S., Gupta, M. K., Tilak, R., & Paik, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.06.757060
Metadata
- Authors
- Falagas, M. E., Apostolou, K. E., & Pappas, V. D.
- Affiliations
- Tufts University (US)
- Alfa Institute of Biomedical Sciences (GR)
- Corresponding author
- Falagas, M. E.
- ORCID
- Falagas, M. E.
- Venue
- European Journal of Clinical Microbiology & Infectious Diseases
- Published
- 2006-06-14
- Volume
- 25
- Issue
- 7
- Pages
- 419-425
- ISSN
- 0934-9723 (ISSN-L)
- 1435-4373
- OpenAlex
- W2089115810
- Semantic Scholar
- aeb27cd38dec2cc6bc8a111d9effed9e8eb45139
- Cited by
- 294
- References
- 21
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 10 · 2023: 8 · 2022: 11 · 2021: 12 · 2020: 14 · 2019: 13 · 2018: 11 · 2017: 13 · 2016: 22 · 2015: 21 · 2014: 20 · 2013: 16 · 2012: 17
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, attributable mortality, invasive fungal infections, length of hospital stay, hospital costs, intensive care unit patients, transplant recipients, comorbidities
- MeSH terms
- Adult, Candida, Candidiasis, Child, Hospitalization, Humans, Length of Stay, Cohort Studies, Case-Control Studies, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.